Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Lynx Therapeutics

Lynx Therapeutics
1992 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
7 FINANCING ROUNDS
Description

Developer of genetic analysis technologies for pharmaceutical, biotechnology and agricultural industries. The company's cloning and sequencing technologies provide comprehensive and quantitative digital gene expression data which is important to systems biology research enabling drug discovery and development companies to research, develop and implement new treatments for improving human health.

Website
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Primary Office
  • 25861 Industrial Boulevard
  • Hayward, CA 94545
  • United States

Lynx Therapeutics Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Lynx Therapeutics‘s full profile, request access.

Request full access to PitchBook

Lynx Therapeutics Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Lynx Therapeutics‘s full profile, request access.

Request full access to PitchBook

Lynx Therapeutics Executive Team (1)

Name Title Board
Seat
Contact
Info
Kevin Corcoran Board Member, President & Chief Executive Officer